Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Investors.biomarin.com save search
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
Published: 2021-12-16 (Crawled : 22:00) - investors.biomarin.com
BMRN S | $90.07 -0.44% -0.43% 780K
|
Health Technology
|
| O: -0.31%
H: 5.57%
C: 3.78%
cardio therapeutics disease gene therapies cardiovascular collaboration gene therapy therapy
BioMarin Appoints Former CEO of Celgene Corporation, Mark Alles, to Board of Directors
Published: 2021-12-15 (Crawled : 22:00) - investors.biomarin.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: 1.52%
H: 1.13%
C: -4.27%
SYRS | $4.72 -7.63% -7.35% 120K
|
Health Technology
|
| O: 0.57%
H: 2.84%
C: -4.55%
BMRN S | $90.07 -0.44% -0.43% 780K
|
Health Technology
|
| O: 2.83%
H: 0.71%
C: -1.66%
ceo cel
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.